Oral administration of the 11β-hydroxysteroid-dehydrogenase type 1 inhibitor RO5093151 to patients with glaucoma: an adaptive, randomised, placebo-controlled clinical study.
| Author | |
|---|---|
| Abstract |
:
Cortisol is involved in the regulation of intraocular pressure (IOP). This study aimed to assess the effect of 11β-hydroxysteroid-dehydrogenase type 1 (11βHSD1) inhibition by oral administration of RO5093151 on IOP. |
| Year of Publication |
:
0
|
| Journal |
:
BMJ open ophthalmology
|
| Volume |
:
1
|
| Issue |
:
1
|
| Number of Pages |
:
e000063
|
| Date Published |
:
2017
|
| DOI |
:
10.1136/bmjophth-2016-000063
|
| Short Title |
:
BMJ Open Ophthalmol
|
| Download citation |
